G'day roboshan,
"An aquisition down the line that might make sense would be a suitable CGMP rated manufacturing facility (in Australia) that could produce (in the future)an expanded product range using Cellestis's technology. Alternatively they could build one. "
Personally, I don't favor that idea (and I doubt that the company would).
The current methodology of having multiple contract manufacturers that compete for our business and provide natural DR and scaleability seems most sensible. Much better for CST to "stick to their knitting".
- Forums
- ASX - By Stock
- earnings boost
G'day roboshan,"An aquisition down the line that might make...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online